MX2014003984A - Metodo para detectar anticuerpos a-beta especificos en una muestra biologica. - Google Patents

Metodo para detectar anticuerpos a-beta especificos en una muestra biologica.

Info

Publication number
MX2014003984A
MX2014003984A MX2014003984A MX2014003984A MX2014003984A MX 2014003984 A MX2014003984 A MX 2014003984A MX 2014003984 A MX2014003984 A MX 2014003984A MX 2014003984 A MX2014003984 A MX 2014003984A MX 2014003984 A MX2014003984 A MX 2014003984A
Authority
MX
Mexico
Prior art keywords
specific antibodies
detecting
biological sample
aggregates
sample
Prior art date
Application number
MX2014003984A
Other languages
English (en)
Inventor
Walter Schmidt
Achim Schirrmacher
Frank Mattner
Günther Staffler
Andreas Mairhofer
Martina Lutterova
Original Assignee
Affiris Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Affiris Ag filed Critical Affiris Ag
Publication of MX2014003984A publication Critical patent/MX2014003984A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4709—Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

La presente invención se relaciona con un método para detectar los anticuerpos Aß específicos en una muestra biológica que comprende las siguientes etapas: - poner en contacto la muestra con los agregados Aß o con partículas que tienen superficies similares al agregado Aß y que permiten que los anticuerpos Aß específicos se unan a los agregados Aß, y - detectar los anticuerpos Aß específicos unidos a los agregados Aß mediante una técnica de detección de partícula simple, de preferencia por clasificación celular activada por fluorescencia, FACS.
MX2014003984A 2011-10-04 2012-09-20 Metodo para detectar anticuerpos a-beta especificos en una muestra biologica. MX2014003984A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11183842.1A EP2579042B1 (en) 2011-10-04 2011-10-04 Method for detecting Aß-specific antibodies in a biological sample
PCT/EP2012/068494 WO2013050249A1 (en) 2011-10-04 2012-09-20 METHOD FOR DETECTING Aß-SPECIFIC ANTIBODIES IN A BIOLOGICAL SAMPLE

Publications (1)

Publication Number Publication Date
MX2014003984A true MX2014003984A (es) 2014-05-07

Family

ID=46888451

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014003983A MX2014003983A (es) 2011-10-04 2012-09-20 Metodo para diagnosticar la enfermedad de alzheimer (ad).
MX2014003984A MX2014003984A (es) 2011-10-04 2012-09-20 Metodo para detectar anticuerpos a-beta especificos en una muestra biologica.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2014003983A MX2014003983A (es) 2011-10-04 2012-09-20 Metodo para diagnosticar la enfermedad de alzheimer (ad).

Country Status (24)

Country Link
US (2) US20140234877A1 (es)
EP (3) EP2579042B1 (es)
JP (2) JP2014529088A (es)
KR (2) KR20140073568A (es)
CN (2) CN103842825B (es)
AR (1) AR088108A1 (es)
AU (2) AU2012320767A1 (es)
BR (2) BR112014008089A2 (es)
CA (2) CA2850840A1 (es)
CY (1) CY1115624T1 (es)
DK (2) DK2579042T3 (es)
ES (2) ES2496341T3 (es)
HK (1) HK1178601A1 (es)
HR (1) HRP20140937T1 (es)
IL (2) IL231057A0 (es)
MX (2) MX2014003983A (es)
PL (2) PL2579042T3 (es)
PT (1) PT2579042E (es)
RS (1) RS53496B1 (es)
RU (2) RU2014117671A (es)
SG (2) SG11201400223SA (es)
SI (1) SI2579042T1 (es)
SM (1) SMT201400145B (es)
WO (2) WO2013050249A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2787349A1 (en) 2013-04-03 2014-10-08 Affiris AG Method for detecting proteinopathy-specific antibodies in a biological sample
EP2787347A1 (en) * 2013-04-03 2014-10-08 Affiris AG Method for detecting Aß-specific antibodies in a biological sample
WO2015165961A1 (en) 2014-04-29 2015-11-05 Affiris Ag Treatment and prevention of alzheimer's disease (ad)
KR101658620B1 (ko) * 2014-12-02 2016-09-23 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
KR20170108203A (ko) 2016-03-16 2017-09-27 주식회사 피플바이오 응집형-형성 폴리펩타이드의 응집형을 검출하는 방법
KR101871895B1 (ko) * 2016-04-20 2018-06-28 한국과학기술연구원 응집 단백질의 고감도 광 산화 증폭 면역 분석을 통한 체액기반의 퇴행성 신경질환 진단 방법
EP3242134A1 (en) * 2016-05-04 2017-11-08 Euroimmun Medizinische Labordiagnostika AG Assay for the diagnosis of a neurological disease
KR101989383B1 (ko) * 2017-04-04 2019-06-14 조선대학교산학협력단 알츠하이머성 치매의 조기진단을 위한 펩타이드 프로브
KR102108171B1 (ko) * 2018-08-27 2020-05-08 광주과학기술원 알츠하이머성 치매 진단용 펩타이드 바이오마커
WO2020045962A1 (ko) * 2018-08-27 2020-03-05 광주과학기술원 알츠하이머성 치매 진단용 펩타이드 바이오마커
CN113075398A (zh) * 2021-03-23 2021-07-06 中国医学科学院输血研究所 一种血浆中特异性IgG抗体的定量测定方法
CN113063949A (zh) * 2021-03-23 2021-07-02 中国医学科学院输血研究所 一种血浆中特异性IgM抗体的定量测定方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262332A (en) * 1989-04-05 1993-11-16 Brigham And Women's Hospital Diagnostic method for Alzheimer's disease: examination of non-neural tissue
AU8083094A (en) * 1994-10-19 1996-05-15 General Hospital Corporation, The A diagnostic assay for alzheimer's disease: assessment of abeta abnormalities
US7427392B1 (en) * 1994-11-14 2008-09-23 Elan Pharmaceuticals, Inc. Methods for aiding in the diagnosis of alzheimer's disease by measuring amyloid-β peptide (x-≧41) and tau
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
UA81216C2 (en) * 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
EP3214175A1 (en) 1999-08-24 2017-09-06 E. R. Squibb & Sons, L.L.C. Human ctla-4 antibodies and their uses
AT413945B (de) 2003-01-14 2006-07-15 Mattner Frank Dr Impfstoff für die alzheimer-krankheit
KR100595494B1 (ko) * 2003-02-24 2006-07-03 (주) 디지탈바이오텍 혈액 내 베타-아밀로이드 항체 농도를 이용한 알츠하이머병 진단키트
AT413336B (de) 2003-09-12 2006-02-15 Mattner Frank Dr Apherese-vorrichtung
AT500483B1 (de) 2004-07-13 2006-01-15 Mattner Frank Dr Set zur vorbeugung oder behandlung der alzheimer'schen erkrankung
AT413946B (de) 2004-07-13 2006-07-15 Mattner Frank Dr Impfstoff gegen die alzheimer-krankheit
DE102005006217B4 (de) * 2005-02-07 2007-08-16 Universitätsklinikum Hamburg-Eppendorf Diagnose von allergischen Erkrankungen und/oder atopischen Erkrankungen durch Nachweis von Autoantikörpern gegen CD28 in humanem Serum
JP4937143B2 (ja) * 2005-03-05 2012-05-23 アボット ゲーエムベーハー ウント カンパニー カーゲー 非拡散性球状Ａβ（Ｘ−３８．．４３）オリゴマー構造エピトープに対して特異性を有する自己抗体を検出する方法
TW200726774A (en) * 2005-06-30 2007-07-16 Merck & Co Inc Composition and method for producing stable amyloid beta oligomers
BRPI0613358A8 (pt) * 2005-07-08 2017-12-26 Dsm Ip Assets Bv ácidos de gordura poli - insaturada para o tratamento da demência e condições relacionadas à pré-demência
KR20150098683A (ko) * 2005-12-12 2015-08-28 에이씨 이뮨 에스.에이. 치료적 특성을 갖는 베타 1-42 특이적인 단일클론성 항체
JP2010515717A (ja) * 2007-01-11 2010-05-13 フィリップス−ウニベルジテート・マールブルク アルツハイマーおよび他の神経性認知症疾患の診断ならびに処置
US7771957B2 (en) * 2007-10-19 2010-08-10 The Regents Of The University Of California Method for diagnosing alzheimer's disease
WO2009051599A1 (en) * 2007-10-19 2009-04-23 The Regents Of The University Of California Use of biomarkers of alzheimer's disease for diagnostic tests and drug screening
AT506535B1 (de) 2008-02-22 2010-04-15 Affiris Forschungs & Entwicklungs Gmbh Vaccine enthaltend alpha-synuclein-mimotope auf basis von peptiden
AT506819B1 (de) 2008-06-12 2011-06-15 Affiris Forschungs Und Entwicklungs Gmbh Vakzin zur behandlung von alzheimer-krankheit
KR20110036809A (ko) 2008-06-12 2011-04-11 아피리스 아게 파킨슨병과 관련된 증상을 치료하기 위한 화합물
AT509611B1 (de) 2008-06-12 2012-04-15 Affiris Forschungs-Und Entwicklungs Gmbh Vakzin
CA2753586A1 (en) * 2009-02-24 2010-09-02 Winton G. Gibbons Detection of complexes of tau and amyloid
WO2010128139A1 (en) 2009-05-08 2010-11-11 Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin Biomarkers and methods for diagnosing alzheimer's disease and/ or mild cognitive impairment
AT508638B1 (de) 2009-08-21 2011-08-15 Affiris Ag Verwendung von peptiden und polypeptiden zur behandlung und/oder prävention von synukleinopathien
WO2011106732A1 (en) * 2010-02-25 2011-09-01 Wyeth Llc Pet monitoring of ab-directed immunotherapy

Also Published As

Publication number Publication date
AR088108A1 (es) 2014-05-07
KR20140073568A (ko) 2014-06-16
SI2579042T1 (sl) 2014-09-30
AU2012320766A1 (en) 2014-03-13
IL231057A0 (en) 2014-03-31
SMT201400145B (it) 2014-11-10
RS53496B1 (en) 2015-02-27
AU2012320766B2 (en) 2017-09-21
RU2014117677A (ru) 2015-11-10
DK2579042T3 (da) 2014-07-21
HK1178601A1 (en) 2013-09-13
CY1115624T1 (el) 2017-01-04
HRP20140937T1 (hr) 2014-12-05
EP2764367B1 (en) 2018-07-25
AU2012320767A1 (en) 2014-03-13
US20140242727A1 (en) 2014-08-28
IL231620A0 (en) 2014-05-28
BR112014008089A2 (pt) 2017-04-18
CN103842824A (zh) 2014-06-04
JP2014529088A (ja) 2014-10-30
CA2850843A1 (en) 2013-04-11
ES2496341T3 (es) 2014-09-18
BR112014008088A2 (pt) 2017-04-18
JP6162127B2 (ja) 2017-07-12
CA2850840A1 (en) 2013-04-11
SG11201400229XA (en) 2014-05-29
PT2579042E (pt) 2014-09-09
PL2579042T3 (pl) 2014-12-31
DK2764367T3 (en) 2018-10-29
CN103842825A (zh) 2014-06-04
WO2013050248A1 (en) 2013-04-11
EP2579042B1 (en) 2014-07-09
ES2692185T3 (es) 2018-11-30
RU2014117671A (ru) 2015-11-10
US20140234877A1 (en) 2014-08-21
CN103842825B (zh) 2016-04-20
MX2014003983A (es) 2014-05-07
SG11201400223SA (en) 2014-05-29
JP2014529087A (ja) 2014-10-30
EP2764367A1 (en) 2014-08-13
US9625459B2 (en) 2017-04-18
WO2013050249A1 (en) 2013-04-11
PL2764367T3 (pl) 2019-04-30
KR20140069346A (ko) 2014-06-09
EP2579042A1 (en) 2013-04-10
EP2764368A1 (en) 2014-08-13

Similar Documents

Publication Publication Date Title
MX2014003984A (es) Metodo para detectar anticuerpos a-beta especificos en una muestra biologica.
EP2654977A4 (en) System and method for inspecting and sorting particles and process for qualifying the same with seed particles
WO2011108909A3 (en) Method and kit for isolating target cell
MX354461B (es) Anticuerpos monoclonales y metodos de deteccion para enzimas que confieren resistencia a la fosfinotricina n acetil transferasa.
WO2013074520A3 (en) Detection, isolation and analysis of rare cells in biological fluids
EP2414539A4 (en) Methods and devices for sorting cells and other biological particulates
ZA201401130B (en) Methods and systems for detecting an analyte in a sample
NZ602220A (en) Antibodies with ph dependent antigen binding
HK1216027A1 (zh) 抗-血樹突狀細胞抗原 抗體及其應用
WO2011088014A3 (en) Systems and methods for counting cells and biomolecules
WO2013166338A3 (en) Cell capture system and use thereof
IN2014DN08957A (es)
SG11201402709WA (en) Method and device for assaying an antigen present on erythrocytes or an antibody binding to an antigen present on erythrocytes
WO2013092611A3 (en) Method for the detection of free binding partner of a multispecific binder
WO2012170206A3 (en) Color-producing diagnostic systems, reagents and methods
NZ605449A (en) Anti-neuropilin antibodies and methods of use
WO2014004609A3 (en) Rapid assays for t-cell activation by rna measurements using flow cytometry
EP2278331A4 (en) LEUKOCYTE ANALYSIS METHOD AND ANALYSIS REAGENT FOR USE IN THE PROCESS
WO2011127001A3 (en) Quantum dot-based optical sensors for rapid detection and quantitative analysis of biomolecules and biological materials
MX2014014566A (es) Metodo para detectar un aglutinante multiespecifico.
IL215322A0 (en) Method for detecting antibody against sith-1 in biological sample
MX2015004419A (es) Deteccion de analito y determinacion de concentracion de analito mediante uso de perlas magnetizables.
WO2007037910A3 (en) Specific removal of activated immune cells
AR095995A1 (es) MÉTODO PARA DETECTAR ANTICUERPOS ESPECÍFICOS ANTI Ab EN UNA MUESTRA BIOLÓGICA
WO2012177930A8 (en) System for handling biological samples

Legal Events

Date Code Title Description
FA Abandonment or withdrawal